Compare ESTA & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTA | ADNT |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | United States | Ireland |
| Employees | 1004 | N/A |
| Industry | Industrial Specialties | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2018 | 2016 |
| Metric | ESTA | ADNT |
|---|---|---|
| Price | $60.19 | $20.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 11 |
| Target Price | ★ $86.86 | $25.32 |
| AVG Volume (30 Days) | 445.7K | ★ 813.4K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $61,208,000.00 | ★ $17,439,000,000.00 |
| Revenue This Year | $28.01 | $2.75 |
| Revenue Next Year | $26.20 | $2.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 76.49 | 7.56 |
| 52 Week Low | $28.67 | $10.18 |
| 52 Week High | $83.31 | $27.32 |
| Indicator | ESTA | ADNT |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 45.41 |
| Support Level | $36.41 | $18.69 |
| Resistance Level | $68.38 | $23.87 |
| Average True Range (ATR) | 3.34 | 0.80 |
| MACD | 0.68 | 0.13 |
| Stochastic Oscillator | 56.79 | 45.35 |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.